Find and Pitch Jounalists, Get Your Story Covered

Tags: gear gadget lab podcast podcasts drugs weight loss

	Profile	Recent Articles on Subject
1	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs - 2 days ago Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study - about 1 year ago
2	Kristen Monaco MedPage Today	CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down - 8 days ago Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6 - 2 months ago Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update - 3 months ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - 4 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 4 months ago Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down - 4 months ago Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss - 5 months ago Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ - 7 months ago Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - 8 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 8 months ago Wegovy Approved for Heart Disease Prevention - 8 months ago Beware of Fake Ozempic, FDA Warns - 11 months ago Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry - 11 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 12 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 12 months ago Tirzepatide Wins FDA Approval for Weight Loss - about 1 year ago Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? - about 1 year ago
3	David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK Technologysciencewriting	Ozempic Gives Strong Relief to Severe Knee Pain, Clinical Trial Suggests - 9 days ago
4	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs - 9 days ago Amgen Puts Its Weight Behind Obesity Drug With Potential Edge Over Lilly, Novo Nordisk Meds - 6 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide - 20 days ago SELECT Trial Shows Similar Cardiac Benefits of Semaglutide for Heart Failure - 3 months ago Study: Unexpected Safety Signals Identified for Semaglutide in Diabetes, Obesity - 4 months ago Teva Launches Generic Formulation of Liraglutide in US - 5 months ago Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients - 7 months ago FDA Approves Semaglutide for New Indication Involving Cardiovascular Disease - 8 months ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - 8 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 9 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 11 months ago
6	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Ozempic Linked With Lower Risk of Alzheimer's Diagnosis - 20 days ago
7	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 2 months ago Can you get satiety with GLP-1s without the nausea? - 4 months ago STAT+: Amgen goes all in on injectable obesity drug as it scraps early-stage pill - 7 months ago
8	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - 2 months ago STAT+: Eli Lilly reports tirzepatide MASH success during Q4 earnings - 9 months ago
9	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	New Firearm Injury Numbers; Another Indication for Semaglutide? - 3 months ago Dulaglutide, Weight Gain, and Smoking Cessation; New Year's Eye Injuries - 11 months ago
10	Katie Palmer STAT News Health tech reporter @statnews. JSK Stanford alum. MA health technologysciencejournalism	Weight loss drugs without a prescription? Study warns it’s a ‘very risky business’ - 3 months ago

Journalists covering semaglutide